MedPath

Wake Network, Inc.

Wake Network, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2019-11-01
Employees
11
Market Cap
-
Website
http://www.wake.net

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults

Phase 2
Withdrawn
Conditions
Anxiety and Depression
Interventions
Dietary Supplement: Oyster mushroom
First Posted Date
2021-08-04
Last Posted Date
2022-06-30
Lead Sponsor
Wake Network, Inc.
Registration Number
NCT04989972
Locations
🇯🇲

FMS Department of Psychiatry, Kingston, Jamaica

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.